Dr John McGrane has been working as a consultant clinical oncologist at the Royal Cornwall Hospital since 2014. He is the clinical lead for radiotherapy at the Royal Cornwall Hospital and specialises in radiotherapy and systemic anti-cancer treatment of urological and gynaecological cancers. 

Alongside his clinical practice he is actively involved in recruiting into clinical trials in urological and gynaecological cancers at the Royal Cornwall Hospital.  He is Principal Investigator for over 30 urology and gynaecology clinical trials with a broad experience in trials. 
He is co-founder of the UK Renal Oncology Collaboration.

Dr McGrane is an expert in digital health solutions for cancer patient follow up and care. In 2018 he co-founded the award winning MySunrise cancer patient support app. 

Dr Michael Rowe is a Clinical Oncologist based in Cornwall having completed speciality training in 2024. He has recently held the position of Chair of the National Oncology Trainees Collaborative for Healthcare Research (NOTCH) and has overseen and run a number of national multicentre studies including the first trainee-led national retrospective observational study on tolerance of anticancer therapy in the elderly (TOASTIE). He is on the study management group for current active NOTCH studies: HNSCCUP (head and neck cancer of unknown primary), ChILI (checkpoint induced liver injury) and DeACT (de-esclation of treatment in anal cancer in patients with comorbidities).
 He has co-authored a national bladder cancer radiotherapy dosing and fractionation guideline for the Royal College of Radiologists. He specialises in the treatment of urological, upper gastrointestinal and hepatobiliary cancers.